Showing results (1-10 of 329) with videos related to
Sort By:
Pageof 33
Translational Research : the Journal of Laboratory and Clinical Medicine|October 11, 2018
Novel biomarkers in multiple myelomaAdam Levin, Parameswaran Hari, Binod DhakalF1000Research|September 10, 2016
Recent advances in understanding multiple myelomaBinod Dhakal, Saulius Girnius, Parameswaran HariJCO Oncology Practice|May 18, 2021
Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm ShiftMeera Mohan, Parameswaran Hari, Binod DhakalAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune TherapyAmrita Krishnan, Ravi Vij, Jesse Keller, et al.Leukemia Research|July 27, 2018
Incidence and survival of therapy related myeloid neoplasm in United StatesGuru Subramanian Guru Murthy, Mehdi Hamadani, Binod Dhakal, et al.Cells|August 27, 2021
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging TherapeuticsHassan Awada, Bicky Thapa, Hussein Awada, et al.Clinical Lymphoma, Myeloma & Leukemia|May 14, 2021
KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary MyelomaAseel Alsouqi, Muhammad Khan, Binod Dhakal, et al.JAMA Network Open|July 6, 2019
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US HospitalsBinod Dhakal, Smith Giri, Adam Levin, et al.British Journal of Haematology|April 8, 2017
Marizomib for central nervous system-multiple myelomaAshraf Badros, Zeba Singh, Binod Dhakal, et al.Hematology/Oncology and Stem Cell Therapy|March 19, 2019
Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced diseaseGina Patel, Parameswaran Hari, Aniko Szabo, et al.Pageof 33